Also called personalized medicine, this evolving field makes use of an individual’s genes, lifestyle, environment and other factors to identify unique disease risks and guide treatment decision-making.
Masimo's MightySat Medical is the first FDA-cleared pulse oximeter available to consumers without a prescription, which could disrupt the market for the notoriously inaccurate at-home devices.
MediView’s technologies utilize AR to provide clinicians with 3D “X-ray vision” guidance during minimally invasive procedures and surgeries, while also offering remote collaboration.
Early on in the development of digital image recognition, the technology showed a penchant for taking logical but potentially problematic shortcuts: It would look to image artifacts and incidental “asides” such as background features to distinguish between two visually similar subjects.
Psychology researchers have used machine learning to wring useful two-year dementia trajectory predictions from more than 500 potentially contributing risk factors.
Before colonoscopy AI can progress from lab to clinic on a broad scale—and win regulatory approvals along the way—it has to show its diagnostic mettle in numerous large clinical trials conducted at multiple facilities.
Emergency physicians have a tough time identifying patients who have Crohn’s disease and truly need a CT scan to pinpoint the cause of acute abdominal distress.
